HbO2 Therapeutics
PA - SoudertonBiotechnology
Focus: HbO2 Therapeutics is a public biotech company focused on hemoglobin-based oxygen carriers, a specialized therapeutic modality. Limited public data constrains full market position assessment.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About HbO2 Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow HbO2 Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
HBOC-201
AnemiaClinical Trials (1)
NCT02684474Expanded Access Protocol Using HBOC-201
N/AHelp build intelligence for HbO2 Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.